Clinical trial
Evaluation of the Effect of Revision Surgery of Lumbar Adjacent Segment Degeneration
NCT04970862 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Effect of Revision Surgery of Lumbar Adjacent Segment Degeneration
- Lead sponsor
- Peking University Third Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- August 1, 2021
- Completion date
- December 30, 2023
- Enrollment
- 120 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
adjacent segment degeneration, adjacent segment disease